{"id":231657,"date":"2026-02-19T18:12:28","date_gmt":"2026-02-20T00:12:28","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/02\/japanese-government-panel-endorses-sumitomo-pharmas-ips-derived-treatment-for-parkinsons"},"modified":"2026-02-19T18:12:28","modified_gmt":"2026-02-20T00:12:28","slug":"japanese-government-panel-endorses-sumitomo-pharmas-ips-derived-treatment-for-parkinsons","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/02\/japanese-government-panel-endorses-sumitomo-pharmas-ips-derived-treatment-for-parkinsons","title":{"rendered":"Japanese government panel endorses Sumitomo Pharma\u2019s iPS-derived treatment for Parkinson\u2019s"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/japanese-government-panel-endorses-sumitomo-pharmas-ips-derived-treatment-for-parkinsons2.jpg\"><\/a><\/p>\n<p>The expert council of the Japanese Ministry of Health has approved two regenerative medicine drugs based on induced pluripotent stem cells (iPSCs) \u2014 a cure for Parkinson\u2019s disease and heart failure. If the health minister approves the experts\u2019 decision, Japan will become the first country in the world to allow the commercial sale of such products \u2014 almost 20 years after the discovery of the technology itself.<\/p>\n<hr>\n<p>Japan\u2019s health ministry said on Thursday a panel of specialists had endorsed Sumitomo Pharma\u2019s iPS cell-derived treatment for Parkinson\u2019s disease, paving the way for the world\u2019s first medical products based on the technology.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The expert council of the Japanese Ministry of Health has approved two regenerative medicine drugs based on induced pluripotent stem cells (iPSCs) \u2014 a cure for Parkinson\u2019s disease and heart failure. If the health minister approves the experts\u2019 decision, Japan will become the first country in the world to allow the commercial sale of such [\u2026]<\/p>\n","protected":false},"author":701,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1490,269],"tags":[],"class_list":["post-231657","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-government","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/231657","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/701"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=231657"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/231657\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=231657"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=231657"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=231657"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}